Physician profile
Aleksandre Toreli
NPI 1346533536
$6,730.14
in general payments reported to CMS, 2019-2025
39 companies · $1,148 in 2025
The $1,148 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $406 · 2020: $615 · 2021: $984 · 2022: $1,023 · 2023: $1,004 · 2024: $1,550 · 2025: $1,148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,703.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,702.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inari Medical, INC. | $965.99 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $897.85 | 2021-2025 | Linq II, Corevalve Evolut R, Micra |
| Novartis Pharmaceuticals Corporation | $526.38 | 2020-2025 | |
| Janssen Pharmaceuticals, INC | $507.32 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $497.04 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $474.57 | 2019-2024 | Eluvia, Wallstent Rp Endoprosthesis, Angiojet Ultra 5000a |
| Abiomed | $388.27 | 2021-2025 | |
| Edwards Lifesciences Corporation | $194.70 | 2019-2025 | Sapien 3 Ultra Resilia |
| Penumbra, INC. | $186.84 | 2024-2025 | Indigo System |
| Biotronik INC. | $185.37 | 2022-2025 | Amvia Edge, Orsiro Mission |
| Shockwave Medical, INC | $181.21 | 2023-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $162.91 | 2019-2025 | Xience Skypoint, Perclose Prostyle, Assurity |
| Argon Medical Devices, INC. | $132.85 | 2023-2025 | Clot Management, Cleaner |
| Csl Behring | $124.77 | 2023-2024 | Kcentra |
| Philips North America LLC | $112.80 | 2024 | (Bq9) Coronary Ivus |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $107.35 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $105.23 | 2021-2024 | Camzyos, Eliquis |
| Astellas Pharma US INC | $94.92 | 2020-2021 | |
| Irhythm Technologies, INC. | $91.61 | 2019-2024 | Zio Monitor, Zio Xt Patch |
| Heartflow, INC. | $86.10 | 2024-2025 | |
| Angiodynamics, INC. | $76.22 | 2025 | Alphavac |
| Lexicon Pharmaceuticals, INC. | $67.62 | 2023-2024 | Inpefa |
| Sanofi-Aventis U.S. LLC | $64.78 | 2019-2021 | |
| Cordis US Corp. | $50.00 | 2025 | Mynx Control Venous |
| Kestra Medical Technology Services, INC. | $44.78 | 2025 | Assure Wcd |
| Merck Sharp & Dohme LLC | $41.21 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $35.84 | 2020-2024 | |
| Convatec INC. | $34.01 | 2023 | |
| Chiesi USA, INC. | $33.97 | 2023-2024 | Kengreal |
| Bard Peripheral Vascular, INC. | $33.20 | 2025 | Crosser Iq |
| Abbvie INC. | $31.82 | 2023 | Ubrelvy |
| Ethicon US, LLC | $28.95 | 2024 | Vistaseal, Dermabond |
| Boehringer Ingelheim Pharmaceuticals, INC. | $27.41 | 2022 | |
| Medtronic Vascular, INC. | $26.94 | 2020 | |
| Amgen INC. | $26.67 | 2021 | |
| Teleflex LLC | $24.21 | 2023 | Guideliner |
| Actelion Pharmaceuticals US, INC. | $23.70 | 2022 | |
| Asahi Intecc USA, INC. | $19.06 | 2023 | Asahi Ptca Guide Wire |
| Alnylam Pharmaceuticals INC. | $15.67 | 2024 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aleksandre Toreli listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.